Herbas VPB

Print
EN | LT
LT - Skysti (S)-N-(5-((R)-2-(2,5-difluorofenil)-pirolidin-1-il)- pirazolo [1,5-a]pirimidin-3-il)-3-hidroksipirolidin-1-karboksamido preparatai
EN - LIQUID FORMULATIONS OF (S)-N-(5-((R)-2-(2,5-DIFLUOROPHENYL)-PYRROLIDIN-1-YL)-PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE-1-CARBOXAMIDE

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/519 (2006.01)
A61P 35/00 (2006.01)
European patent
(11) Number of the document 3439662
(13) Kind of document T
(96) European patent application number 17718256.5
Date of filing the European patent application 2017-04-04
(97) Date of publication of the European application 2019-02-13
(45) Date of publication and mention of the grant of the patent 2024-07-24
(46) Date of publication of the claims translation 2024-10-10
PCT application
(86) Number PCT/US2017/025939
Date 2017-04-04
PCT application publication
(87) Number WO 2017/176751
Date 2017-10-12
Priority applications
(30) Number Date Country code
201662318041 P 2016-04-04 US
201662323452 P 2016-04-15 US
201662329561 P 2016-04-29 US
Inventors
(72)
REYNOLDS, Mark , US
SMITH, Steven A. , US
Grantee
(73) Loxo Oncology, Inc. , 281 Tresser Boulevard 9th Floor, Stamford, Connecticut 06901, US
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Skysti (S)-N-(5-((R)-2-(2,5-difluorofenil)-pirolidin-1-il)- pirazolo [1,5-a]pirimidin-3-il)-3-hidroksipirolidin-1-karboksamido preparatai
  LIQUID FORMULATIONS OF (S)-N-(5-((R)-2-(2,5-DIFLUOROPHENYL)-PYRROLIDIN-1-YL)-PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE-1-CARBOXAMIDE
Last renewal fee
Payment date Validity (years) Amount
2025-02-27 9 208.00 EUR
Next renewal fee
2026-04-04